Notogen is developing a novel biologic regenerative therapy to treat degenerative disc disease (i.e. chronic back and neck pain as a result of degenerating spinal discs). The product, which is pre-clinical and currently undergoing cGMP manufacturing, is an injectable solution that is fast to administer, cost-effective, and minimally invasive to patients. The unique approach helps the body arrest degeneration and repair and regenerate spinal disc tissues, while reducing pain and inflammation.
Based on more than 20 years of clinical and laboratory research, this novel therapeutic has the potential to improve the lives of millions of people worldwide suffering from chronic back and neck pain.
Notogen is headquartered in Toronto, Canada.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 661 University Avenue, Suite 13-1387,canada
- Phone
- 647-243-5278
- Industry
- Biotechnology
- Website
- notogen.com
- HQ
- Toronto, Ontario
Notogen Inc. Questions
Notogen Inc.'s helpline number is 647-243-5278
Notogen Inc.'s website is notogen.com
Notogen Inc.'s LinkedIn profile is https://ca.linkedin.com/company/notogeninc.
Notogen Inc. has
4 employees.
View email and phone details for 4
employees at Notogen Inc..
Notogen Inc.'s industry is
Biotechnology
Notogen Inc.'s top competitors are
Organobiotech, Inc.,
Omniabio,
Noa Therapeutics,
Notch Therapeutics,
Axolotl Biosciences,
Allarta Life Science Inc.,
Breathe Biomedical Inc.,
Fendx Technologies Inc.,
Avivo Biomedical Inc.,
Amacathera.
Notogen Inc.'s categories are Biotechnology
Notogen Inc.'s founding year is 2016
